Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Lilly’s Solanezumab Slows Down Alzheimer’s Progression

Solanezumab, an experimental Eli Lilly medication for Alzheimer’s disease, slowed the rate of cognitive decline and memory loss by approximately 30% among patients in early stages of the disease. Eli Lilly says the results of its latest clinical trial provides initial evidence that solanezumab may have an impact on the course of the disease…

Go to Source

Leave a Reply

News

Immunotherapy effective against ‘untreatable’ prostate cancer

For the first time, a major clinical trial shows that immunotherapy can successfully treat very advanced forms of prostate cancer. Powered by WPeMatico

more >

Breast cancer: New immunotherapy leads to complete regression

A new and improved form of immunotherapy led to complete regression of breast cancer in a patient who had not responded to any other treatments. Powered by WPeMatico

more >

Stroke: Clinical trial results ‘likely to change care practice’

A large international clinical trial suggests that an anticoagulant and aspirin combination may be the way to go when it comes to preventing major stroke. Powered by WPeMatico

more >

Parkinson’s: Targeting new compound slows disease in rats

The results of a decade-long study are in: a new therapeutic target is found, and scientists manage to slow the progression of the disease in animals. Powered by WPeMatico

more >

Added to chemotherapy, this drug doubles lung cancer survival

Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations. Powered by WPeMatico

more >

New drug halves previously untreatable migraine attacks

A new compound, called erenumab, was found to be successful in treating migraines for which other treatments had previously failed. Powered by WPeMatico

more >